# ioneer Ltd: financial statements, quarterly

IONR · Nasdaq · CIK 1896084 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ionr.md) · [Financials](/companies/ionr/financials.md) · [Filings](/companies/ionr/filings.md) · [Insiders](/companies/ionr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ionr/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2020-06-30) | period not labelled (2021-06-30) | period not labelled (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [26.3](/filings/0001140361-23-049907.md) | [62.5](/filings/0001140361-24-043965.md) | [94.2](/filings/0001140361-25-038934.md) | [52.7](/filings/0001140361-25-038934.md) | [35.7](/filings/0001140361-25-038934.md) | [25.1](/filings/0001140361-25-038934.md) |
| Current assets | $m | not reported | [62.7](/filings/0001140361-23-049907.md) | [94.3](/filings/0001140361-23-049907.md) | [53.1](/filings/0001140361-24-043965.md) | [36.1](/filings/0001140361-25-038934.md) | [25.3](/filings/0001140361-25-038934.md) |
| Total assets | $m | not reported | [149](/filings/0001140361-23-049907.md) | [213](/filings/0001140361-24-043965.md) | [206](/filings/0001140361-25-038934.md) | [224](/filings/0001140361-25-038934.md) | [234](/filings/0001140361-25-038934.md) |
| Current liabilities | $m | not reported | [5.4](/filings/0001140361-23-049907.md) | [9.5](/filings/0001140361-24-043965.md) | [8.8](/filings/0001140361-25-038934.md) | [6.2](/filings/0001140361-25-038934.md) | [3.0](/filings/0001140361-25-038934.md) |
| Total liabilities | $m | not reported | [5.5](/filings/0001140361-23-049907.md) | [9.5](/filings/0001140361-24-043965.md) | [8.9](/filings/0001140361-25-038934.md) | [6.3](/filings/0001140361-25-038934.md) | [3.2](/filings/0001140361-25-038934.md) |
| Shareholders' equity | $m | [98.5](/filings/0001140361-23-049907.md) | [144](/filings/0001140361-24-043965.md) | [204](/filings/0001140361-25-038934.md) | [197](/filings/0001140361-25-038934.md) | [218](/filings/0001140361-25-038934.md) | [230](/filings/0001140361-25-038934.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 2,674,633,957 at 2025-12-31, from the cover of the [20-F filed 2026-04-29](/filings/0001140361-26-017853.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.